Neutralization of SARS-CoV-2 Variants in Transplant Recipients After Two and Three Doses of mRNA-1273 Vaccine

  • Deepali Kumar
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
  • Victor H. Ferreira
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
  • Victoria G. Hall
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
  • Queenie Hu
    Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, Toronto, Ontario, Canada (Q.H.)
  • Reuben Samson
    Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (R.S., A.G.).
  • Terrance Ku
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
  • Matthew Ierullo
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
  • Beata Majchrzak-Kita
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
  • George Tomlinson
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)
  • Anne-Claude Gingras
    Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Sinai Health, and Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada (R.S., A.G.).
  • Atul Humar
    University Health Network, Toronto, Ontario, Canada (D.K., V.H.F., V.G.H., T.K., M.I., B.M., G.T., A.H.)

書誌事項

タイトル別名
  • Secondary Analysis of a Randomized Trial

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

  • CRID
    1360861711981156352
  • DOI
    10.7326/m21-3480
  • ISSN
    15393704
    00034819
  • データソース種別
    • Crossref

問題の指摘

ページトップへ